GEN-1 immunotherapy for the treatment of ovarian cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Future oncology"
DOI: 10.2217/fon-2018-0423
Abstract: GEN-1 is a gene-based immunotherapy, comprising a human IL-12 gene expression plasmid and a synthetic plasmid delivery system, delivered intraperitoneally (ip.) to produce local and persistent levels of a pleiotropic immunocytokine, IL-12, at the tumor… read more here.
Keywords: gen immunotherapy; immunotherapy treatment; ovarian cancer; gen ... See more keywords